Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors

EMBO Journal

Volumn 16, Issue 18, 1997, Pages 5608-5617

  Alimandi, Maurizio ^c   Wang, Ling Mei ^c   Bottaro, Donald ^c   Lee, Chong Chou ^c   Kuo, Angera ^c   Frankel, Mark ^a   Fedi, Paolo ^a   Tang, Careen ^b   Lippman, Marc ^b   Pierce, Jacalyn H ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Betacellulin; Epidermal growth factor; ErbB2 receptor; ErbB3 receptor; Signal transduction

Indexed keywords

BETACELLULIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 3; NEU DIFFERENTIATION FACTOR; TYROSINE;

ANIMAL CELL; ARTICLE; BINDING SITE; BREAST CARCINOMA; CARCINOMA CELL; CELL PROLIFERATION; CHIMERA; CONTROLLED STUDY; CROSS LINKING; DNA SYNTHESIS; GENETIC TRANSFECTION; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BINDING SITES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL LINE; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; MICE; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION;

ANIMALIA; MURINAE;

EID: 0030799298     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.18.5608     Document Type: Article

References (64)

1. Alimandi, M., Romano, A., Curia, M.C., Muraro, R., Fedi, P., Aaronson, S.A., Di Fiore, P.P. and Kraus, M.H. (1995) Cooperative signaling of erbB3 and erbB2 in neoplastic transformation and human malignancies. Oncogene, 10, 1813-1821.
2. Bates, S.E., Davidson, N., Valverius, E., Freter, C., Dickson, R., Tam, J., Kudlow, J., Lippman, M. and Salomon, D.S. (1988) Expression of transforming growth factor α and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol. Endocrinol., 2, 543-555.
3. Carraway, K.L., III and Cantley, L.C. (1994) A neu acquaintance for ErbB3 and ErbB4: a role for receptor heterodimerization in growth signaling. Cell, 78, 5-8.
4. Carraway, K.L., III et al. (1994) The erbB-3 gene product is a receptor for heregulin. J. Biol. Chem., 269, 14303-14306.
5. Carraway, K.L., III, Soltoff, S.P., Diamonti, A.J. and Cantley, L.C. (1995) Heregulin stimulates mitogensis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3. J. Biol. Chem., 270, 7111-7116.
6. Ciardiello, F. et al. (1989) Transforming growth factor α (TGFα) mRNA expression in human breast carcinomas and TGFα activity in the effusions of breast cancer patients. J. Natl Cancer Inst., 81, 1165-1171.
7. Ciardiello, F. et al. (1990) Transforming growth factor-α expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene and overexpression of the transforming growth factor-α complementary DNA leads to transformation. Cell Growth Differ., 1, 407-420.
8. Cunningham, B.C., Ultsch, M., de Vos, A.M., Mulkerrin, M.G., Clauser, K.R. and Wells, J.A. (1991) Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science, 254, 821-825.
9. Derynck, R., Goeddel, D.V., Ullrich, A., Gutterman, J.U., Williams, R.D., Bringman, T.S. and Berger, W.H. (1987) Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res., 47, 707-712.
10. Di Fiore, P.P., Segatto, O., Taylor, W.G., Aaronson, S.A. and Pierce, J.H. (1990) EGF receptor and ErbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science, 248, 79-83.
11. DiMarco, E., Pierce, J.H., Fleming T.P., Kraus, M.H., Molloy, C.J., Aaronson, S.A. and DiFiore, P.P. (1989) Autocrine interaction between TGFα and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene, 4, 831-838.
12. Earp, H.S., Dawson, T.L., Xiong, L. and Hong, Y. (1995) Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res. Treat., 35, 115-132.
13. Elenius, K., Paul, S., Allison, G., Sun, J. and Klagsbrun, M. (1997) Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J., 16, 1268-1278.
14. Falls, D.L., Rosen K.M., Corfas, G., Lane, W.S. and Fischback, G.D. (1993) ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family. Cell, 72, 801-815.
15. Fazioli, F., Minichiello, L., Matoska, V., Castagnino, P., Miki, T., Wong, W.T. and DiFiore, P.P. (1993) Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals. EMBO J., 12, 3799-3808.
16. Fedi, P., Pierce, J.H., Di Fiore, P.P. and Kraus, M.H. (1994) Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase Cγ or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other Erb/EGFR family members. Mol. Cell. Biol., 14, 492-500.
17. Goustin, A.S., Leof, E.B., Shipley, G.D. and Moses H.L. (1986) Growth factors and cancer. Cancer Res., 46, 1015-1029.
18. Graus-Porta, D., Beerli, R.R., Daly, J.M and Hynes, N.E. (1997) ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J., 16, 1647-1655.
19. Groenen, L.C., Nice, E.C. and Burgess, A.W. (1994) Structure-function relationships for the EGF/TGF-alpha family of mitogens. Growth Factors., 11, 235-257.
20. Gullick, W.J. (1991) Prevalence of aberrant expression of epidermal growth factor receptor in human cancer cells. Br. Med. Bull., 47, 87-98.
21. erbB3 possesses an impaired tyrosine kinase activity. Proc. Natl Acad. Sci. USA, 91, 8132-8136.
22. Heldin, C.H. (1995) Dimerization of cell surface receptors in signal transduction. Cell, 80, 213-223.
23. Higashiyama, S., Abraham, J.A., Miller, J., Fiddes, J.C. and Klagsbrun, M. (1991) A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science, 251, 936-939.
24. erbB2. Science, 256, 1205-1210.
25. Hynes, N.E. and Stern, D.F. (1994) The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta, 1198, 165-184.
26. Karunagaran, D., Tazhar, E., Beerli, R.R., Chen, X., Graus-Porta, D., Wen, D., Seger, R., Hynes, N.E. and Yarden, Y. (1996) ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implication for breast cancer. EMBO J., 15, 254-264.
27. Kita, Y.A. et al. (1994) NDF/heregulin stimulates the phosphorylation of HER3/erbB3. FEBS Lett., 349, 139-143.
28. Kokai, Y., Myers, J.N., Wada, T., Brown, V.I., LeVea, C.M., Davis, J.G., Dobashi, K. and Greene, M. (1989) Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell, 58, 287-292.
29. Kraus, M.H., Fedi, P., Starks, V., Muraro, R. and Aaronson, S.A. (1989) Isolation and characterization of ErbB3, a third member of the ErbB/ epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl Acad. Sci. USA, 86, 9193-9197.
30. Lemmon, M.A., Bu, Z., Ladbury, J.E., Zhou, M., Pinchasi, D., Lax, I., Engelman, D. and Schlessinger, J. (1997) Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J., 16, 281-294.
31. Lonardo, F., Di Marco, El, King, E.R., Pierce, J.H., Segatto, O., Aaronson, S.A. and Di Fiore, P.P. (1990) The normal erbB2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand. New Biol., 2, 992-1003.
32. Marchionni, M.A. et al. (1993) Glial growth factors are alternatively spliced erbB-2 ligands expressed in the nervous system. Nature, 362, 312-319.
33. Marquart, H.M., Hunkapiller, W., Hood, L.E. and Todaro, G.J. (1984) Rat transforming growth factor type I: structure and relation to epidermal growth factor. Science, 223, 1079-1082.
34. Marte, B., Graus-Porta, D., Jeschke, M., Fabbro, D., Hynes, N.E. and Taverna, D. (1995) NDF/heregulin activates MAP kinase p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells. Oncogene, 10, 167-175.
35. Peles, E. and Yarden, Y. (1993) Neu and its ligands: from an oncogene to neural factors. BioEssays, 15, 815-824.
36. Peles, E., Bacus, S.S., Koski, R.A., Lu, H.S., Wen, D., Ogden, S.G., BenLevy, R. and Yarden Y. (1992) Isolation of the Neu/HER-2 stimulatory ligand: a 44kd glycoprotein that induces differentiation of mammary tumor cells. Cell, 69, 205-216.
37. Peles, E., BenLewy, R., Tazhar, E., Liu, N., Wen, D. and Yarden, Y. (1993) Cell type specific interaction of Neu differentiation factor (NDF/ heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships. EMBO J., 12, 961-971.
38. Perroteau, I., Salomon, D.S., DeBortoli, M., Kidwell, W., Hazarika, P., Pardue, R., Dedman, J. and Tam, J. (1986) Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells. Breast Cancer Res. Treat., 7, 201-210.
39. Philo, J.S., Aoki, K.H., Arakawa, T., Narhi, L.O. and Wen, J. (1996) Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction. Biochemistry, 35, 1681-1691.
40. Pierce, J.H., Ruggiero, M., Fleming, T.P., Di Fiore, P.P., Greenberger, J.S., Varticovski, L., Schlessinger, J., Rovera, G. and Aaronson, S.A. (1988) Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells. Science, 239, 628-631.
41. Pinkas-Kramarski, R. et al. (1996a) Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interaction. EMBO J., 15, 2452-2467.
42. Pinkas-Kramarski, R., Shelly, M., Glathe, S., Ratzkin, B.J. and Yarden, Y. (1996b) Neu differentiation factor/Neuregulin isoforms activate distinct receptor combination. J. Biol. Chem., 271, 19029-19032.
43. Pinkas-Kramarski, R., Alroy, I and Yarden, Y. (1997) ErbB receptors and EGF-like ligands: Cell lineage determination and oncogenesis through combinatorial signaling. J. Mammary Gland Biol. Neoplasia, 2, 97-107.
44. p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl Acad. Sci. USA, 90, 1746-1750.
45. p180erbB4. Nature, 366, 473-475.
46. Pringent, S.A. and Gullick, W.J. (1994) Identification of c-erbB-3 binding sites for phosphatidylinositol 3′-kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO J., 13, 2831-2841.
47. Riese, D.J., II, van Raaij, T.M., Plowman, G.D., Andrews, G.C. and Stern, D.F. (1995) The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol. Cell. Biol., 15, 5770-5776.
48. Riese, D.J., II, Bermingham, Y., van Raaij, T.M., Buckley, S., Plowman, G.D. and Stern, D.F. (1996a) Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene, 12, 345-353.
49. Riese, D.J., Kim, E.D., Elenius, K., Buckley, S., Klagsbrun, M., Plowman, G.D. and Stern, D. (1996b) The epidermal growth factor receptor couples transforming growth factor-α, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB4. J. Biol. Chem., 271, 20047-20052.
50. Salomon, D.S., Brandt, R., Ciardiello, F. and Normanno, N. (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol.-Hematol, 19, 183-232.
51. Savage, C.R., Jr, Inagami, T. and Cohen, S. (1972) The primary structure of epidermal growth factor. J. Biol. Chem., 247, 7612-7621.
52. Schlessinger, J. and Ullrich, A. (1990) Signal transduction by receptors with tyrosine kinase acivity. Cell, 61, 203-212.
53. String, Y., Christofori, G., Hanahan, D., Ono, Y., Sasada, R., Igarashi, K. and Folkman, J. (1993) Betacellulin: a mitogen from pancreatic beta cell tumors. Science, 259, 1604-1607.
54. Shoyab, M.G., Plowman, G., McDonald, V.L., Bradley, J.G. and Todaro G.J. (1989) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 243, 1074-1076.
55. Sliwkowski, M.X. et al. (1994) Co-expression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J. Biol. Chem., 269, 14661-14665.
56. Soltoff, S.P., Carraway, K.L., III, Prigent, S.A., Gullick, W.G. and Cantley, L.C. (1994) erbB-3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol. Cell. Biol., 14, 3550-3558.
57. Tazhar, E. et al. (1994) erbB-3 and erbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/ heregulin isoforms. J. Biol. Chem., 269, 25226-25233.
58. Toyoda, H., Komuasaki, T., Uchida, D., Takayama, Y., Isobe, T., Okuyama, T. and Hanada, K., (1995) Epiregulin, A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J. Biol. Chem., 270, 7495-7500.
59. Travers, M.T., Barrett-Lee, P.J., Berger, U., Lugmani, Y.A., Gazet, J.C., Powels, T.J. and Coombes, C.R. (1988) Growth factor expression in normal, benign and malignant breast tissue. Br. Med. J., 296, 1621-1625.
60. Ullrich, A. et al. (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature, 309, 418-425.
61. Wallasch, C., Weiss, F.U., Niederfellner, G., Jallal, B., Issing, W. and Ullrich, A. (1995) Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J., 14, 4267-4275.
62. Wang, L.-M., Myers, M.G., Sun, X.-J., Aaronson, S.A., White, M. and Pierce, J.H. (1993) IRS-1: Essential for insulin-and IL-4-stimulated mitogenesis in hematopoietic cells. Science, 261, 1591-1594.
63. Weissman, B. and Aaronson, S.A. (1983) Balb and Kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent balb/c mouse epidermal keratinocyte lines. Cell, 32, 599-606.
64. Wen, D. et al. (1992) Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell, 69, 559-572.